The Oncology Institute, Inc. (TOI)
After hours:
| Previous Close | 0.4707 |
| Open | 0.4951 |
| Bid | 0.5000 x 100 |
| Ask | 0.5097 x 100 |
| Day's Range | 0.4706 - 0.5200 |
| 52 Week Range | 0.3300 - 2.6550 |
| Volume | |
| Avg. Volume | 182,576 |
| Market Cap | 36.787M |
| Beta (5Y Monthly) | 0.83 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
The Oncology Institute to Participate at Upcoming Investor Conferences
CERRITOS, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate at the following investor conferences: Jefferies Global Healthcare ConferenceDate: June 6th, 2024Fireside Chat: 9:00am Eastern TimeTOI Participant: Daniel Virnich, M.D., MBA, Chief Executive OfficerLocation: New York City, NY Truist Securities Health
- GlobeNewswire
The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference
CERRITOS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) have announced their executives’ participation in multiple panel presentations at the upcoming APG 2024 Spring Conference in San Diego. Chief Medical Officer, Dr. Yale Podnos, will be discussing artificial intelligence and its uses in an oncology practice in the breakout session panel “AI on the Front Lines: Improving Outcomes and Reducing Costs for Complex Patients”. Dr. Danie
- GlobeNewswire
The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance
CERRITOS, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2024. Recent Operational Highlights Include: Successfully completed integration of first capitated risk contract direct to a health plan, and launched MSO model to enhance employed clinic locations, in the Florida market, effective
